US Patent Protection for Pulmaquin™ Is Extended with Issuance of a Composition of Matter Patent

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation announced that the USPTO has issued an important composition of matter patent regarding its lead preparation, Pulmaquin™. The patent provides exclusivity until October 22, 2028.

Feed Date: 
February 21, 2012